πŸ‡ΊπŸ‡Έ FDA
Patent

US 6333321

Selective factor Xa inhibitors

expired A61KA61K38/00

Quick answer

US patent 6333321 (Selective factor Xa inhibitors) held by COR Therapeutics, Inc. expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
54
CPC classes
A61K, A61K38/00